Immunovant Inc. (IMVT) Debt to Equity Ratio
Immunovant Inc. (IMVT) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2020-03-31 | 0.16 |
| 2021-03-31 | 0.05 |
| 2022-03-31 | 0.10 |
| 2023-03-31 | 0.12 |
| 2024-03-31 | 0.08 |
| 2025-03-31 | 0.10 |
Get Immunovant Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("IMVT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IMVT | $24.73 | +0.47% | 0.92M |
| 3 | ||||
| 4 | ||||
| 5 |